Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Intern Med J ; 42(8): 944-7, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22906028

RESUMEN

We describe a case of headache and neurological deficits with cerebrospinal fluid (CSF) lymphocytosis in a patient presenting with a 3-week history of recurrent severe headaches associated with negative sensory symptoms and dysphasia. The patient had no cardiovascular risk factors and no family history of migraines. Neurological examination was unremarkable. Cerebral magnetic resonance imaging was unremarkable. CSF analysis revealed lymphocytosis (leucocytes 84 × 10(6)/L, 100% lymphocytes). Extensive laboratory investigations of CSF and serum did not reveal an infectious, autoimmune or metabolic cause. Visual evoked potentials were normal. Awake electroencephalogram revealed intermittent 3-5 Hz generalised slowing and frontal intermittent rhythmic delta activity, without epileptiform discharges. Repeat CSF analysis showed marked reduction of the total leucocyte count and remained negative for infectious aetiology. Propranolol was commenced, and no recurrence of headache or neurological symptoms was observed at follow-up. An extensive literature review on the topic is discussed.


Asunto(s)
Electroencefalografía , Cefalea/líquido cefalorraquídeo , Linfocitosis/líquido cefalorraquídeo , Enfermedades del Sistema Nervioso/líquido cefalorraquídeo , Adolescente , Electroencefalografía/métodos , Femenino , Cefalea/complicaciones , Cefalea/diagnóstico , Humanos , Linfocitosis/complicaciones , Linfocitosis/diagnóstico , Enfermedades del Sistema Nervioso/complicaciones , Enfermedades del Sistema Nervioso/diagnóstico , Síndrome
2.
Intern Med J ; 40(10): 716-20, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21038537

RESUMEN

Reversible posterior leukoencephalopathy syndrome (RPLS) is a potentially devastating early complication of calcineurin inhibitor (CNI) therapy in solid organ transplantation. Management centres on cessation of CNI therapy; however, this strategy is complicated in lung transplantation because of the threat of allograft rejection, or, if CNI is replaced with mammalian target of rapamycin-based immunosuppression, poor wound healing and bronchial dehiscence. We describe four cases of RPLS after lung transplantation, emphasizing the diagnostic and management approach required to maintain a healthy allograft and ensure that RPLS is, as the name suggests, reversible.


Asunto(s)
Terapia de Inmunosupresión , Trasplante de Pulmón , Síndrome de Leucoencefalopatía Posterior/diagnóstico , Síndrome de Leucoencefalopatía Posterior/terapia , Adolescente , Adulto , Manejo de la Enfermedad , Femenino , Supervivencia de Injerto/inmunología , Humanos , Terapia de Inmunosupresión/efectos adversos , Terapia de Inmunosupresión/métodos , Trasplante de Pulmón/efectos adversos , Trasplante de Pulmón/inmunología , Masculino , Persona de Mediana Edad , Síndrome de Leucoencefalopatía Posterior/inmunología , Estudios Retrospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...